Collagen loaded nano-sized surfactant based dispersion for topical application: Formulation development, characterization and safety study

Pharmaceutical Development and Technology

Volumn 19, Issue 4, 2014, Pages 460-467

  Ahmad, Iqbal ^a   Akhter, Sohail ^a,b   Ahmad, Mohammad Zaki ^c   Shamim, Mohd ^a   Rizvi, Mushahid Alam ^d   Khar, Roop K ^a   Ahmad, Farhan J ^a  

^a HAMDARD UNIVERSITY   (India)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NAJRAN UNIVERSITY   (Saudi Arabia)

^d JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Collagen; Histopathology; Nano surfactant dispersion; Niosome and topical delivery; Skin hydration test; Skin irritation test

Indexed keywords

ALCOHOL; CHOLESTEROL; COLLAGEN; NANO SURFACTANT; SORBITAN STEARATE; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; HISTOPATHOLOGY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SKIN IRRITATION; STRATUM CORNEUM; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ZETA POTENTIAL;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; COLLAGEN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GELS; HEXOSES; MALE; NANOPARTICLES; PARTICLE SIZE; RABBITS; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS;

EID: 84899974837     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2013.795167     Document Type: Article

References (35)

1. Di Lullo GA, Sweeney SM, Korkko J, et al. Mapping the ligandbinding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 2002;277: 4223-4231.
2. Veit G, Kobbe B, Keene DR, et al. Collagen XXVII, a novel von Willebrand factor, a domain-containing protein with many imperfections in the collagenous domain. J Biol Chem 2006;52: 3494-3504.
3. Maeda M, Tani S, Sano A, Fujioka K. Microstructure and release characteristics of the minipellet, a collagen based drug delivery system for controlled release of protein drugs. J Cont Rel 1999;62: 313-324.
4. Jerome A, Ramshaw JA. Collagen-based biomaterials. Clin Mater 1992;9:137-138.
5. Kaufman HE, Steinemann TL, Lehman E, et al. Collagen based drug delivery and artificial tears. J Ocul Pharmacol 1994;10:17-27.
6. Rao KP. Recent developments of collagen-based materials for medical applications and drug delivery systems. J Biomater Sci 1995;7:623-645.
7. Lucas PA, Syftestad GT, Goldberg VM, Caplan AI. Ectopic induction of cartilage and bone by water soluble proteins from bovine bone using a collagenous delivery vehicle. J Biomed Mater Res 1989;23:23-39.
8. Fonseca MJ, Alsina MA, Reig F. Coating liposomes with collagen (Mr 50000) increases uptake into liver. Biochim Biophys Acta 1996; 1279:259-265.
9. Thacharodi D, Rao KP. Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: development and in vitro evaluations. Biomaterials 1996;17:1307-1311.
10. Rossler B, Kreuter J, Scherer D. Collagen microparticles: preparation and properties. J Microencapsulation 1995;12:49-57.
11. Ruszczak Z, Friess W. Collagen as a career for on-site delivery of antibacterial drugs. Adv Drug Del Rev 2003;55:1679-1698.
12. Wallace DG, Rosenblatt J. Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Del Rev 2003;55: 1631-1649.
13. Sadick NS, Karcher C, Palmisano L. Cosmetic dermatology of the aging face. Clin Dermatol 2009;27:S3-12.
14. Yamauchi M, Mechanic G. Cross-linking of collagen. In: Nimmi ME, ed. Collagen. Boca Raton: CRC Press; 1988:157-172.
15. Hannachi Imen E, Nakamura M, Mie M, Kobatake E. Construction of multifunctional proteins for tissue engineering: epidermal growth factor with collagen binding and cell adhesive activities. J Biotechnol 2009;139:19-25.
16. Bauman L. CosmoDerm/Cosmoplast (human bioengineered collagen) for the aging face. Facial Plast Surg 2004;20:125-128.
17. Sanchez-Carpintero I, Candelas D, Ruiz-Rodriguez R. Dermal fillers: types, indications, and complications. Actas Dermosifiliogr 2010;101:381-393.
18. Mahale NB, Thakkar PD, Mali RG, et al. Niosomes: novel sustained release nonionic stable vesicular systems - an overview. Adv Colloid Interface Sci 2012;183-184:46-54.
19. Shaikh KS, Chellampillai B, Pawar AP. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. Drug Dev Ind Pharm 2010;36:946-953.
20. Shakeel F, Ramadan W, Gargum HM, Singh R. Preparation and in vivo evaluation of indomethacin loaded true nanoemulsions. Sci Pharm 2010;78:47-56.
21. Zeisig R, Shimada K, Hirota S, Arndt D. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. Biochim Biophys Acta Biomembranes 1996;1985: 237-245.
22. Akhter S, Kushwaha S, Warsi MH, et al. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir. Drug Dev Ind Pharm 2012;38:84-92.
23. Manconi M, Sinico C, Valenti D, et al. Niosomes as carriers for tretinoin III. A study into the in vitro cutaneous delivery of vesicleincorporated tretinoin. Int J Pharm 2005;311:11-19.
24. Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 2005;306: 71-82.
25. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery - an overview. Acta Pharmaceut Sin B 2011;1:208-219.
26. Heurtault B, Saulnier P, Pech B, et al. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003;24:4283-4300.
27. Haskell RJ, Shifflett JR, Elzinga PA. Particle-sizing technologies for submicron emulsions. In: Benita S, ed. Submicron emulsions in drug targeting and delivery. Amsterdam: Harwood Academic Publishers; 1998:21-98.
28. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998;172:33-70.
29. Devaraj GN, Parakh SR, Devraj R, et al. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Coll Interf Sci 2002;251:360-365.
30. Hao Y, Zhao F, Li N, et al. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002;244:73-80.
31. Manosroi A, Wongtrakul P, Manosroi J, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloid Surf B Biointerf 2003;30:129-138.
32. Raja NRA, Chandrashekhar G, Pillai GK, et al. Antiinflammatory activity of niosome encapsulated diclofenac sodium with Tween-85 in arthritic rats. Ind J Pharmacol 1994;26:46-48.
33. Namdeo A, Jain NK. Niosomal delivery of 5-fluorouracil. J Microencapsulation 1999;16:731-740.
34. Cable C. An examination of the effects of surface modifications on the physicochemical and biological properties of non-ionic surfactant vesicles. PhD Thesis, University of Strathclyde, Glasgow, UK; 1989.
35. Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 2005;59:485-490.